| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-291X(03)01190-2 |
| P698 | PubMed publication ID | 12859967 |
| P50 | author | Beat Schafer | Q64729772 |
| P2093 | author name string | Claus W Heizmann | |
| Nobuyuki Sasaki | |||
| Hsiao-Ling Hsieh | |||
| P2860 | cites work | RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides | Q22010236 |
| Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma | Q28141359 | ||
| S100A1, a new marker for acute myocardial ischemia | Q28142557 | ||
| Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family | Q28301899 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease | Q33939347 | ||
| Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations | Q34399633 | ||
| RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease | Q34836475 | ||
| S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes. | Q38281887 | ||
| Validation of tissue microarray technology in breast carcinoma | Q38462822 | ||
| Expression pattern of S100 calcium-binding proteins in human tumors | Q40920348 | ||
| Calcium-binding protein S100A4 in health and disease | Q40977827 | ||
| Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts | Q41009444 | ||
| Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma | Q41093031 | ||
| Protein S100A4: too long overlooked by pathologists? | Q41867135 | ||
| Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma | Q42279613 | ||
| Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells | Q43848237 | ||
| beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. | Q46404934 | ||
| Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins | Q48283333 | ||
| Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease | Q49097822 | ||
| Immunohistochemical localization of the Ca2+binding S100 proteins in normal human skin and melanocytic lesions | Q56016553 | ||
| S100A2, a Putative Tumor Suppressor Gene, Regulates In Vitro Squamous Cell Carcinoma Migration | Q58862285 | ||
| Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases | Q59084980 | ||
| Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer | Q63966034 | ||
| Metastasis-associated mts1 gene expression correlates with increased p53 detection in the B16 murine melanoma | Q72681838 | ||
| Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation | Q73010823 | ||
| Identification of MRP-8 (calgranulin A) as a major responsive protein in chronic periodontitis | Q73290656 | ||
| Multiple tissue core arrays in histopathology research: a validation study | Q73290666 | ||
| Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer | Q73645121 | ||
| Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness | Q74287469 | ||
| Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases | Q74806366 | ||
| Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy | Q77828869 | ||
| The identification and differential expression of calcium-binding proteins associated with ocular melanoma | Q77910506 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 375-381 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays | |
| P478 | volume | 307 |
| Q36482032 | A CXCL1 paracrine network links cancer chemoresistance and metastasis |
| Q39246681 | All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses |
| Q35048039 | Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function |
| Q34056610 | Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling |
| Q36112558 | Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer |
| Q28553904 | Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast |
| Q37938716 | Calcium-binding protein S100P and cancer: mechanisms and clinical relevance |
| Q35591343 | Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion |
| Q36701812 | Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology |
| Q94101433 | Current Awareness on Comparative and Functional Genomics |
| Q33592541 | Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma |
| Q91632927 | Downregulation of RAGE Inhibits Cell Proliferation and Induces Apoptosis via Regulation of PI3K/AKT Pathway in Cervical Squamous Cell Carcinoma |
| Q37229916 | Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer |
| Q33284424 | Endogenous secretory receptor for advanced glycation endproducts as a novel prognostic marker in chondrosarcoma |
| Q35803624 | Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancer |
| Q35579991 | Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B |
| Q33683985 | Large-scale proteomic identification of S100 proteins in breast cancer tissues |
| Q39192067 | Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells. |
| Q36425962 | Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma |
| Q46408405 | Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy |
| Q93195668 | RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer |
| Q38234624 | Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury |
| Q43245445 | S100 protein family and its application in clinical practice |
| Q38338396 | S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors |
| Q34700918 | S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway |
| Q36820542 | Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines |
| Q27652244 | Structure of the S100A6 Complex with a Fragment from the C-Terminal Domain of Siah-1 Interacting Protein: A Novel Mode for S100 Protein Target Recognition † ‡ |
| Q38743691 | Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis. |
| Q36057340 | The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinoma |
| Q37055940 | The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells |
| Q80517354 | The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas |
| Q33633330 | The receptor for advanced glycation end products (RAGE) and the lung |
| Q38621771 | Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site. |
| Q33792824 | mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer |
Search more.